BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 26597737)

  • 21. Primary Aldosteronism: Present and Future.
    Funder JW
    Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary aldosteronism caused by aldosterone-producing adenoma in pregnancy--complicated by EPH gestosis.
    Kreze A; Kothaj P; Dobáková M; Rohon S
    Wien Klin Wochenschr; 1999 Oct; 111(20):855-7. PubMed ID: 10586491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of successful outcome in patients with primary aldosteronism.
    Moo TA; Zarnegar R; Duh QY
    Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
    Riester A; Reincke M
    Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Aldosteronism Presenting with Hypertension Five Days after Delivery: A Case Report and Literature Review.
    Ohara N; Kobayashi M; Yoneoka Y; Hasegawa G; Aoki Y; Nakamura Y; Kazama Y; Nishiyama T
    Intern Med; 2022 Feb; 61(4):507-512. PubMed ID: 34393169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
    Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
    Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eplerenone use in primary aldosteronism during pregnancy.
    Cabassi A; Rocco R; Berretta R; Regolisti G; Bacchi-Modena A
    Hypertension; 2012 Feb; 59(2):e18-9. PubMed ID: 22146514
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy-resistant hypertension--the value of aldosterone antagonists].
    Quack I; Reincke M; Rump LC
    MMW Fortschr Med; 2007 Nov; 149(46):39-40. PubMed ID: 18069192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of primary hyperaldosteronism.
    Araujo-Castro M
    Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
    Young WF
    Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
    Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
    Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of secondary hypertension causing miscarriage during the first trimester of pregnancy].
    Fikri Benbrahim O; García Agudo R; Cazalla Cadenas F; Martínez Calero A; González-Spínola J
    Nefrologia; 2011; 31(2):229-31. PubMed ID: 21461023
    [No Abstract]   [Full Text] [Related]  

  • 35. The evaluation and treatment of endocrine forms of hypertension.
    Velasco A; Vongpatanasin W
    Curr Cardiol Rep; 2014 Sep; 16(9):528. PubMed ID: 25119722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cushing's syndrome during pregnancy secondary to adrenal adenoma.
    Borna S; Akbari S; Eftekhar T; Mostaan F
    Acta Med Iran; 2012; 50(1):76-8. PubMed ID: 22267384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
    Carey RM
    Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestation of aldosteronoma.
    Al Fehaily M; Duh QY
    Surg Clin North Am; 2004 Jun; 84(3):887-905. PubMed ID: 15145241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and therapy of endocrine hypertension].
    Unger N; Petersenn S; Mann K
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():170-2. PubMed ID: 16802547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.